So how can you tell whether it is a fall, or an accidental bruise and not an injury inflicted by a caregiver – when you are not around to monitor your loved one?

One essential quality lacking in today’s Alzheimer’s care is a genuine respect for the patient. The diagnosis of cognitive impairment carries the stigma of “losing your mind,” “senility,” or “being empty headed.” Here are some tips to restore dignity to the cognitively impaired.

At Maryland’s School of Pharmacy research is being conducted to either validate or refute the theory that the extract of ginkgo biloba leaves can at best prevent or at least delay the symptoms of Alzheimer’s disease.

New research suggests that a drug like Aricept might be helpful in the early stages of mild impairment.

The brains of Alzheimer’s patients in the early stages are larger in those who are physically fit than those who do not exercise!

There is an even more insidious toll on the caregiver which is an erosion of personal health and a shorter lifespan!

A new drug, Flurizan, which is actually on the horizon could potentially change the preventive landscape of Alzheimer’s. Flurizan is claimed to reduce the amount of toxic beta amyloid in an Alzheimer’s brain.

Some surprising news is on the horizon, from an antihistamine which originated in Russia in the 1980’s, Dimebon.

Dr. John Ratey, a Harvard Medical School Professor and author of SPARK presents impressive evidence that aerobic exercise improves the brain´s functions and increases the growth of new brain cells to boost memory and mood.

Treating symptoms, reliable early diagnosis, addressing disease triggers and reversing poor cognition are the exciting directions of research in Alzheimer’s Disease.